SCHEMBL29800012

SCHEMBL29800012

CNC(=O)c1c(N(Cc2ccccc2)C(C)=O)sc2c(Cl)c(O)ccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 1/20 0.37
▸ TSPO P30536 1/20 0.37
▸ KMT2A Q03164 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ NPC1 O15118 4/20 0.34
▸ RAB9A P51151 4/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ PAX8 Q06710 2/20 0.34
▸ GLA P06280 1/20 0.34
▸ NR1H4 Q96RI1 1/20 0.34
▸ DYRK1A Q13627 1/20 0.33
▸ MAPT P10636 1/20 0.32
▸ NR3C1 P04150 1/20 0.32
▸ LTB4R2 Q9NPC1 1/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ TRPM8 Q7Z2W7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24683226 1.00 PDK1 (0.37) PDK1TSPOKMT2AMEN1L3MBTL1
SCHEMBL24682203 0.90 MEN1 (0.39) PDK1KMT2AMEN1NPC1RAB9A
SCHEMBL29800055 0.89 TSPO (0.40) TSPOKMT2AMEN1L3MBTL1NPC1
SCHEMBL24682198 0.89 TSPO (0.40) TSPOKMT2AMEN1L3MBTL1NPC1
SCHEMBL30701659 0.88 KMT2A (0.34) KMT2AMEN1SMN1; SMN2ALDH1A1HTT
SCHEMBL24682972 0.88 KMT2A (0.34) KMT2AMEN1SMN1; SMN2ALDH1A1HTT
SCHEMBL29799821 0.88 HSP90AA1 (0.39) TSPOKMT2AMEN1L3MBTL1NPC1
SCHEMBL24683203 0.88 HSP90AA1 (0.39) TSPOKMT2AMEN1L3MBTL1NPC1
SCHEMBL24682820 0.86 KMT2A (0.35) KMT2AMEN1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL24682207 0.86 TSHR (0.38) PDK1TSPOKMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed
WO-2022173329-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Акционерное общество "Отисифарм" 2022-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 PDK1 1882/4885TSPO 4234/4885KMT2A 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback